KLC-89279-54387
3 vaccinations
6 coded responses
27 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 620 / IL
- Registered
- 2021-07-08
- Relationship
- Child or adolescent in my care
- Guardian
- 7PL-23523-48903
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-08
Registered in v-safe
-
2021-07-08
Dose 1 — Pfizer-BioNTech
-
2021-07-08
Survey response — day 0, dose 1, dependentMedDRA: Pain in extremity — Feeling: Good · Site: Pain, Redness · Muscle or body achesFree text: Arm pain were shot was given. Lasted about 2-3 hours.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-09
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain, Redness · NoneAdult check-in
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-15
- 2021-07-23
-
2021-07-29
Dose 2 — Pfizer-BioNTech
-
2021-07-30
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Fatigue, Headache — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do their normal daily activitiesFree text: Bad headache and tiredness.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-31
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-08-01
-
2021-08-02
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Ocular hyperaemia — Feeling: GoodFree text: Red/blood shot eyes.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-03
- 2021-08-04
- 2021-08-05
-
2021-08-15
Survey response — day 14, dose 2, dependentMedDRA: Headache — Feeling: Good · Be unable to do their normal daily activitiesFree text: HeadacheMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-21
- 2021-08-28
- 2021-09-04
- 2021-10-31
-
2022-02-07
Dose 3 — Pfizer-BioNTech
-
2022-03-11
Survey response — day 28, dose 3, dependentMedDRA: Nasal congestion, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to work or attend schoolFree text: Stuffy nose, runny nose, some sneezing.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-15
- 2022-03-23
- 2022-05-13
- 2022-08-12
-
2023-02-09
Survey response — 12 months, dose 3, dependentMedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-08 | Pfizer-BioNTech | No |
| 2 | 2021-07-29 | Pfizer-BioNTech | No |
| 3 | 2022-02-07 | Pfizer-BioNTech | No |
Free text
Release 9 — day 0, dose 1, dependent
Systemic reaction (other): Arm pain were shot was given. Lasted about 2-3 hours.
Release 9 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Bad headache and tiredness.
Systemic reaction (other): Red/blood shot eyes.
Release 9 — day 14, dose 2, dependent
Symptoms: Headache
Release 11 — day 28, dose 3, dependent
Symptoms: Stuffy nose, runny nose, some sneezing.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Fatigue | ✓ | · | ✓ |
| SRO | Headache | ✓ | · | ✓ |
| SRO | Ocular hyperaemia | ✓ | · | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release